News
The Characterisation of Urothelial Cancer Cells "UC3" project funded by the Brittany region, Rennes Métropole and the ERDF aims to deepen our…
Allan Rodriguez (CEO and co-founder of VitaDX) and Pascal Eschwège (Professor of Urology at the University Hospital of Nancy and co-founder of…
VitaDX is very happy to be a Health & Wellness Laureate at DeepTech4Good !
VitaDX is very pleased to be part of the 5 Therapeutic Innovation Startups selected by AstraZeneca to be part of the support program REALIZE!
Five years of efforts to transform a patented technology into an industrialised solution, tested and certified.
VitaDX citée dans Le Télégramme à l'occasion de la journée Numérique & Santé.
VitaDX citée dans Le Mag numérique à l'occasion de la journée Numérique & Santé.
Interview of Allan Rodriguez, innovation guest in the France Culture Soft Power radio program.
VitaDX among the 20 best rated french startups.
The Characterisation of Urothelial Cancer Cells "UC3" project funded by the Brittany region, Rennes Métropole and the ERDF aims to deepen our…
Allan Rodriguez (CEO and co-founder of VitaDX) and Pascal Eschwège (Professor of Urology at the University Hospital of Nancy and co-founder of…
VitaDX is very happy to be a Health & Wellness Laureate at DeepTech4Good !
VitaDX is very pleased to be part of the 5 Therapeutic Innovation Startups selected by AstraZeneca to be part of the support program REALIZE!
Five years of efforts to transform a patented technology into an industrialised solution, tested and certified.
VitaDX citée dans Le Télégramme à l'occasion de la journée Numérique & Santé.
VitaDX citée dans Le Mag numérique à l'occasion de la journée Numérique & Santé.
Interview of Allan Rodriguez, innovation guest in the France Culture Soft Power radio program.
VitaDX among the 20 best rated french startups.